Iron-chelating agent desferrioxamine stimulates formation of neutrophil extracellular traps (NETs) in human blood-derived neutrophils

• Published in: Bioscience reports Vol. 36; no. 3
• Main Authors: Völlger, Lena, Akong-Moore, Kathryn, Cox, Linda, Goldmann, Oliver, Wang, Yanming, Schäfer, Simon T, Naim, Hassan Y, Nizet, Victor, von Köckritz-Blickwede, Maren
• Format: Journal Article
• Language: English
• Published: England Portland Press Ltd 01.07.2016
• Subjects: Cells, Cultured; Deferoxamine - pharmacology; Extracellular Traps - drug effects; Extracellular Traps - immunology; Extracellular Traps - microbiology; Humans; Immunity, Innate; Iron Chelating Agents - pharmacology; Neutrophils - drug effects; Neutrophils - immunology; Neutrophils - microbiology; Original Paper; Original Papers; Peptide Hydrolases - immunology; Protein-Arginine Deiminases - immunology; Reactive Oxygen Species - immunology; innate immunity; extracellular traps; neutrophils
• ISSN: 0144-8463; 1573-4935
• DOI: 10.1042/BSR20160031

Neutrophil extracellular trap (NET) formation is a significant innate immune defense mechanism against microbial infection that complements other neutrophil functions including phagocytosis and degranulation of antimicrobial peptides. NETs are decondensed chromatin structures in which antimicrobial components (histones, antimicrobial peptides and proteases) are deployed and mediate immobilization of microbes. Here we describe an effect of iron chelation on the phenotype of NET formation. Iron-chelating agent desferrioxamine (DFO) showed a modest but significant induction of NETs by freshly isolated human neutrophils as visualized and quantified by immunocytochemistry against histone-DNA complexes. Further analyses revealed that NET induction by iron chelation required NADPH-dependent production of reactive oxygen species (ROS) as well as protease and peptidyl-arginine-deiminase 4 (PAD4) activities, three key mechanistic pathways previously linked to NET formation. Our results demonstrate that iron chelation by DFO contributes to the formation of NETs and suggest a target for pharmacological manipulation of NET activity.